Spotlight Growth
No Result
View All Result
Friday, February 3, 2023
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
No Result
View All Result
No Result
View All Result
Home Cannabis

A Look At Curaleaf Holdings, Inc. (CSE: CURA), the Latest U.S.-Based Cannabis Company to Go Public on the Canadian Stock Exchange (CSE)

by admin
November 3, 2018
in Cannabis
0
Curaleaf Holdings CSE CURA Recent Marijuana RS US Company News.

Curaleaf Holdings CSE CURA Recent Marijuana RS US Company News.

Like several other U.S.-based cannabis producers, Curaleaf Holdings, Inc. (CSE: CURA) chose to undergoing the listing process to have its shares trade on the Canadian Stock Exchange (CSE). The company just began trading recently on Monday, October 29, 2018 and with a valuation of around $4 billion. The company currently operates twenty-eight pot shops and twelve production sites across twelve U.S. states.

Curaleaf Holdings, Inc. Logo
Curaleaf Holdings, Inc. Logo

Despite marijuana’s illegality in the U.S., the CSE allows Curaleaf, along with other U.S.-based cannabis producers, to list their shares on the exchange. CSE listings don’t receive as much supervision in comparison to the major U.S exchanges or even the Toronto Stock Exchange, or TSX.

Curaleaf CEO Joe Lusardi told MarketWatch during a telephone interview Monday that “we cannot list in the U.S. at the moment, or the TSX, so it was the most logical place to go.”

“Touching the plant” is marijuana industry terminology for firms that are involved in the cultivation of actual pot plants. Curaleaf falls under this category and it has bases in Florida, New York, and Oregon. It operates in states where medicinal cannabis is legal and is attempting to expand into states that have recently legalized weed for adult recreational use, such as California. This shouldn’t be too challenging as Curaleaf can produce 63,000 pounds of dried cannabis flower at its current twelve facilities, per CSE documentation.

Curaleaf has received some comparison to Canopy Growth Corp. (NYSE: CGC) (TSX: WEED),  one of Canada’s largest licensed cannabis producers. Both businesses want to control private retail sales and are vertically-integrated. Some rival companies like Aurora Cannabis, Inc. (NYSE: ACB) (TSX: ACB) and Cronos Group, Inc. (NASDAQ: CRON) (TSX: CRON) have taken a different approach to their retail strategies.

Lusardi stated that “there is certainly a conflict between federal and state law. In all of our operations, we operate fully in compliant with state law. In each market that we are in, cannabis doesn’t cross state lines, we operate under the rules. It’s a state-by-state operation.”

Monday’s listing was completed by a reverse takeover when Curaleaf merged with Lead Ventures, Inc., which raised $400 million through a private placement offering. Curaleaf is planning to spend a portion of those funds on acquisitions.

According to the CSE, Curaleaf is strategizing acquisitions in Maryland, Massachusetts, Nevada, and Arizona for a total of roughly $83.5 million. It also plans to spend $80 million on more cultivation plants.

GMP Securities analyst, Robert Fagan, wrote to clients that he is projecting total sales from Curaleaf’s existing facilities to be roughly $491 million. In the fiscal second quarter, Curaleaf grossed $14.6 million with adjusted losses of $10.4 million. One key reason behind Curaleaf’s success is that it grows the marijuana it sells.

Mr. Fagan mentioned that Curaleaf has “emerged as a new industry leader” and is the largest public cannabis company in the United States. He also gave Curaleaf a “buy” rating with a target price of around $20.

Curaleaf sold shares at C$11.45 in its private placement. The stock started trading at C$10 last Monday and closed at C$7.30 that day. Shares of Curaleaf Holdings rebounded throughout the week and ended Friday’s trading at a price of C$10.95.

Disclaimer: The author and Spotlight Growth has no positions in any of the stocks mentioned in this article. Nor does either party currently have any relationship, or any other conflicts of interest, with any of the companies mentioned in this article. This content is meant for informational and entertainment purposes only and should not be meant as a recommendation to buy or sell any securities. Please visit a licensed financial representative to determine what investments are right for you.

Article By: Donald Brewster

Tags: ACBAurora CannabisCanadacannabiscannabis actcannabis newsCanopy GrowthCGCcommon stockCronos GroupCSECURACuraleaf Holdingsemerging growthinvestinginvestmentmarijuana IPOmarijuana stocksmedical cannabismedical marijuanamicrocap stocksnewspot stockspublic companyrecreational marijuanasalesservicessmall cap companiessmall cap stockssmall capsSpotlight GrowthSpotlight Growth Stocksstock marketstockstradingUS cannabis companies
  • Trending
  • Comments
  • Latest
Asure Software NASDAQ ASUR Human Capital Management HCM Industry Spotlight Growth

Asure Software (NASDAQ: ASUR) is Expanding to Meet the Rising Demand for Human Capital Management Software

September 27, 2022
OLB Group NASDAQ OLB Cuentas NASDAQ CUEN Partnership Fintech Spotlight Growth

OLB Group (NASDAQ: OLB) and Cuentas (NASDAQ: CUEN) Team Up to Bring Fintech Solutions to Over 32,000 Bodegas Across the United States

October 6, 2022
Siyata Mobile NASDAQ SYTA SYTAW SD7 VK7 Purchase Orders Spotlight Growth

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

December 14, 2021
Telcoin TEL Crypto Spotlight Growth

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

June 15, 2021
Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

0
Safe-T SFET NASDAQ UN Presentation

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

0
Safe-T Group SFET Q4 FY 2020 Financial Results

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

0
Safe-T Group NASDAQ SFET FY 2020 Prelim

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

0
Elys Game Technology Corp NASDAQ ELYS Completes Acquisition of Engage IT Services Spotlight Growth

Elys Game Technology Corp (NASDAQ: ELYS) Completes Acquisition of Engage IT Services, a Software Engineering and IT Development Company

February 2, 2023
Tenax Therapeutics NASDAQ TENX US Patent Levosimendan PH-HFpEF Spotlight Growth

Tenax Therapeutics (NASDAQ: TENX) Granted U.S. Patent for IV Levosimendan for Pulmonary Hypertension with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)

February 2, 2023
Versus Systems NASDAQ VS Resolve Debt Partner AI Gamification Consumer Debt Spotlight Growth

Versus Systems (NASDAQ: VS) and Resolve Debt Partner to Integrated Generative AI and Gamification to Customer Payments and Credit Markets

February 1, 2023
Finding the Most Accurate Technical Analysis Indicator Spotlight Growth

Finding the Most Accurate Technical Analysis Indicator

January 31, 2023
ADVERTISEMENT

Recent News

Elys Game Technology Corp NASDAQ ELYS Completes Acquisition of Engage IT Services Spotlight Growth

Elys Game Technology Corp (NASDAQ: ELYS) Completes Acquisition of Engage IT Services, a Software Engineering and IT Development Company

February 2, 2023
Tenax Therapeutics NASDAQ TENX US Patent Levosimendan PH-HFpEF Spotlight Growth

Tenax Therapeutics (NASDAQ: TENX) Granted U.S. Patent for IV Levosimendan for Pulmonary Hypertension with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)

February 2, 2023

Categories

  • Bio/Med/Pharma
  • Cannabis
  • Commodities
  • Consumer Goods
  • Crowdfunding
  • Crypto Cheat Sheets
  • Cryptocurrency
  • Earnings
  • Education
  • Entertainment
  • Financials
  • Market News
  • Opinion
  • Politics
  • Real Estate
  • Split Watch
  • Sponsored
  • Store
  • Technology
  • Uncategorized
  • Venture Capital/Private Equity (VC/PE)

Site Navigation

  • Disclosures
  • Terms Of Service
  • Privacy Policy
  • Contact Us

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

No Result
View All Result
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

Newsletter Signup

Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.

Enter your email address

Thanks, I’m not interested